Skip to main content
HR 1271 115th Congress House

DXM Abuse Prevention Act of 2017

Official title: To amend the Federal Food, Drug, and Cosmetic Act to prevent the abuse of dextromethorphan, and for other purposes.

Introduced: June 5, 2018 See on congress.gov
Health Child healthCivil actions and liabilityDrug safety, medical device, and laboratory regulationDrug trafficking and controlled substances
More subjectsShow fewer subjects
Drug, alcohol, tobacco useLicensing and registrationsPrescription drugsRetail and wholesale trades
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 17, 2017
Referred to the Subcommittee on Health.
Mar 1, 2017
Referred to the House Committee on Energy and Commerce.
Mar 1, 2017
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action March 17, 2017

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

DXM Abuse Prevention Act of 2017

This bill amends the Federal Food, Drug, and Cosmetic Act to: (1) require a retailer that sells certain drugs containing dextromethorphan (DXM) to have a verification system that is intended to ensure that no one under 18 years of age purchases such drugs from the retailer, (2) establish other restrictions on the sale of over-the-counter drugs containing DXM, and (3) establish restrictions on the distribution of bulk DXM.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 4
All 4 Democratic 3
D
Clarke, Yvette D.
New York · Jun 5, 2018
 D
Tonko, Paul
New York · Dec 6, 2017
Meehan, Patrick
· Nov 13, 2017
 D
Matsui, Doris O.
California · Mar 1, 2017
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1271: DXM Abuse Prevention Act of 2017. 115th Congress. Open America. https://openamerica.io/bill/115-HR-1271/
MLA
"H.R. 1271: DXM Abuse Prevention Act of 2017." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-1271/.
Bluebook (legal)
H.R. 1271, 115th Cong. (2026), https://openamerica.io/bill/115-HR-1271/.
Markdown link
[H.R. 1271: DXM Abuse Prevention Act of 2017](https://openamerica.io/bill/115-HR-1271/)
Report a problem